Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInMed Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
InMed Pharmaceuticals Inc. Earnings Date And Information
InMed Pharmaceuticals Inc. last posted its earnings results on Friday, September 29th, 2023. The company reported $-12.92 earnings per share for the quarter, topping analysts' consensus estimates of $-85 by $72.08. The company had revenue of 1.26 B for the quarter and had revenue of 4.60 M for the year. InMed Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-1.0071 diluted earnings per share) and currently has a price-to-earnings ratio of -0. InMed Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, September 19th, 2025 based on prior year's report dates.
InMed Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2025 | Q3 2025 | N/A | -$1.94 | N/A | N/A | $1.26 B |
| 02/12/2025 | Q2 2025 | N/A | -$3.64 | N/A | N/A | $1.11 B |
| 11/14/2024 | Q1 2025 | N/A | -$2.71 | N/A | $1.26 M | $1.26 M |
| 09/27/2024 | Q4 2024 | N/A | -$0.22 | N/A | $2.44 M | $1.28 M |
| 05/13/2024 | Q3 2024 | N/A | -$0.24 | N/A | $2.02 M | $1.17 M |
| 02/13/2024 | Q2 2024 | N/A | -$0.25 | N/A | $1.49 M | $1.24 M |
| 11/13/2023 | Q1 2024 | N/A | -$1.04 | N/A | $1.88 M | $1.69 M |
| 12/21/2023 | Q4 2023 | N/A | -$0.13 | N/A | $1.73 M | $2.31 M |
| 05/15/2023 | Q3 2023 | -$90.00 | -$0.81 | 89.19 | $889.97 K | $1.03 M |
| 02/17/2023 | Q2 2023 | -$90.00 | -$1.24 | 88.76 | $671.82 K | $469.78 K |
| 11/14/2022 | Q1 2023 | N/A | -$5.60 | N/A | $685.41 K | $320.79 K |
| 09/23/2022 | Q4 2022 | -$110.00 | -$15.73 | 94.27 | $965.68 K | $514.76 K |
| 05/13/2022 | Q3 2022 | -$115.00 | -$7.68 | 107.32 | $386.82 K | $309.59 K |
| 02/14/2022 | Q2 2022 | -$120.00 | -$9.78 | 110.22 | $159.31 K | $265.09 K |
| 11/10/2021 | Q1 2022 | -$175.00 | -$7.81 | 167.19 | $380.13 K | $0 |
| 09/24/2021 | Q4 2021 | -$170.00 | -$12.55 | 157.45 | N/A | $0 |
| 05/13/2021 | Q3 2021 | -$120.00 | -$12.91 | 107.09 | N/A | $0 |
| 02/11/2021 | Q2 2021 | -$120.00 | -$11.72 | 108.28 | N/A | $0 |
| 12/16/2020 | Q1 2021 | N/A | -$10.20 | N/A | N/A | $0 |
| 06/30/2020 | Q4 2020 | N/A | -$10.51 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
InMed Pharmaceuticals Inc. Earnings: FAQ's
InMed Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, September 19th, 2025 based offlast year's report dates.
In the previous quarter, InMed Pharmaceuticals Inc. (:INM) reported $-12.92 earnings per share (EPS) to beat the analysts' consensus estimate of $-85 by $72.08.
The conference call for InMed Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for InMed Pharmaceuticals Inc.'s latest earnings report can be read online.
InMed Pharmaceuticals Inc. (:INM) has a recorded annual revenue of $4.60 M.
InMed Pharmaceuticals Inc. (:INM) has a recorded net income of $-7,675,550.InMed Pharmaceuticals Inc. has generated $-1.0071 earnings per share over the last four quarters.
InMed Pharmaceuticals Inc. (:INM) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is 0.